|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Hematologic malignancy
Efficacy of Salvage Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Including Chimeric Antigen Receptor T-Cell Therapy: A Systematic Review and Meta-Analysis
Jinchul Kim, Jinhyun Cho, Sang Eun Yoon, Won Seog Kim, Seok Jin Kim
Cancer Res Treat.
2023;55(3):1031-1047. Published online March 13, 2023 DOI:
https://doi.org/10.4143/crt.2022.1658
Web of Science 1
Crossref 1
Breast cancer
Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience
Ji-Yeon Kim, Seok Jin Nam, Jeong Eon Lee, Jonghan Yu, Byung Joo Chae, Se Kyung Lee, Jai Min Ryu, Jin Seok Ahn, Young-Hyuck Im, Seok Won Kim, Yeon Hee Park
Cancer Res Treat.
2022;54(4):1091-1098. Published online January 10, 2022 DOI:
https://doi.org/10.4143/crt.2021.901
Web of Science 7
Crossref 7
A Modified NHL-BFM-95
Regimen
Produces Better Outcome Than HyperCVAD in Adult Patients with T-Lymphoblastic Lymphoma, a Two-Institution Experience
Chun Li, Zhi-Jun Wuxiao, Xiaoqin Chen, Guanjun Chen, Yue Lu, Zhongjun Xia, Yang Liang, Hua Wang
Cancer Res Treat.
2020;52(2):573-585. Published online December 6, 2019 DOI:
https://doi.org/10.4143/crt.2019.542
Web of Science 4
Crossref 5
Outcomes of Modified FOLFOX-6 as First Line Treatment in Patients with Advanced Gastric Cancer in a Single Institution; Retrospective Analysis
Han Hong Lee, Hoon Hur, Soo Hong Kim, Ae Ryung Park, Wook Kim, Hae Myung Jeon
Cancer Res Treat.
2010;42(1):18-23. Published online March 31, 2010 DOI:
https://doi.org/10.4143/crt.2010.42.1.18
Crossref 12
The Effect of Cytosine Arabinoside and Daunorubicin(AD) Combination Chemotherapy in Acute Myelogeous Leukemia
Chang Hoon Moon, Sung Hyun Kim, Hyung Ryoul Park, Jung Hwan Cho, Hyok Chan Kwon, Jae Seok Kim, Hyo Jin Kim
J Korean Cancer Assoc.
1998;30(4):842-852.
Effect of Cytosine Arabinoside and Daunorubicin (AD) Combination Chemotherapy in Acute Myelogenous Leukemia
Yeoung Sook Kang, Hyun Sik Jeong, Tae Seok Kim, Hyun Seon Yun, Deuk Jo Kim, Jeong Ho Yun, Seong Goyng Lee, Hyeon Gyoo Ji, Gui Hyun Ham, Jae Hoon Lee, Dong Bok Shin
J Korean Cancer Assoc.
1997;29(1):160-170.
COP - BLAM Combination Chemotherapy for the Treatment of Intermediate and High Grade Non - Hodgkin's Lymphoma
Jae Seong Lee, Jang Su Suh, Myung Soo Hyun
J Korean Cancer Assoc.
1994;26(5):806-815.
1
Journal Impact Factor 4.6
> Browse Articles > Search
